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Abstract
Background: Evidence on the differences in symptom patterns between older palliative cancer and non-cancer
patients is lacking. The purpose of the study was to determine the differences in symptoms between older
hospitalised palliative cancer and non-cancer patients.
Methods: A secondary analysis of two multi-centre cross-sectional studies was performed. A validated instrument was
used to assess the frequency and intensity of 40 symptoms in older hospitalised palliative cancer patients (n = 100) and
older palliative non-cancer patients (n = 100). The data were collected between March 2013 and June 2015. Differences
between groups were measured statistically.
Results: Overall, similarities in symptom patterns were observed between cancer and non-cancer patients. Some minor
differences were detected between the groups. Non-cancer patients experienced significantly more physical symptoms
and functional dependence than cancer patients. Patients with cancer experienced higher levels of frequency and
intensity of psychological symptoms compared to non-cancer patients.
Conclusions: Healthcare professionals should be aware of the high occurrence of symptoms in both cancer and non-
cancer patients, and they should be educated about the systematic assessment of symptoms in multiple domains by
accounting for the occurrence of generic symptoms and disease-specific symptoms.
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Background
In palliative care, which aims to improve the quality of life
of patients facing multiple symptoms related to a life-
threatening illness and that of their family, particular em-
phasis is placed on the assessment and management of
symptoms [1]. For some time, palliative care has focused
on the care of patients with cancer [2]. Currently, more at-
tention is devoted to introducing palliative care early in
the trajectory of patients facing chronic illnesses other
than cancer [2]. However, the referral of these patients to
palliative care remains difficult because of the unpredict-
able course of chronic illness and the lack of adequate
education on palliative care in caregivers [3].
Two systematic reviews have examined the occurrence of
symptoms in patients with advanced cancer and other
chronic illnesses [4, 5]. The authors of both reviews ob-
served that cancer and non-cancer patients experienced
multiple symptoms, with some commonalities in symptom
patterns between the two groups [4, 5]. However, these
conclusions were based on their interpretation of the data
rather than on the statistical measurement of a difference
between groups. Moreover, the authors concluded that
most studies focused on physical symptoms and that only a
few studies investigated social and existential symptoms.
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Additionally, Moens, Higginson, & Harding (2014) noted
that more research is needed to compare symptoms in can-
cer and non-cancer patients using the same instrument and
time point [4].
The available evidence focuses on adults in general [4, 5].
The results of these studies cannot be generalised to older
populations (patients aged 65 years and older) due to the
changes in physiology related to the ageing process and the
higher prevalence of multimorbidity in this population [6].
Consequently, older patients are more vulnerable to experi-
encing a complex interplay of multiple problems and symp-
toms in different domains, concerning not only the physical
domain but also the psychological, social, existential, and
functional domains [7].
To our knowledge, there is a lack of evidence on the
differences in symptom patterns between older palliative
cancer and non-cancer patients. In accordance with
Solano et al. (2006) and Moens et al. (2014), our hypoth-
esis is that there is no difference in the experience of
symptoms by older cancer versus non-cancer patients.
This might strongly suggest that the need for palliative
care should be need-based rather than diagnosis-based.
In the last years, a need-based referral is given more at-
tention, but remains difficult in clinical care.
Methods
Aim
The aim of this study was to determine the differences
in (i) the number of symptoms per patient group and (ii)
the frequency and intensity of symptoms between hospi-
talised older palliative cancer and non-cancer patients.
Design
A secondary analysis of two multi-centre cross-sectional
studies was performed. The first study focused on the
frequency and intensity of symptoms and the treatments
administered in hospitalised older patients with cancer
and need of palliative care [8]. The second study was
part of a study that focused on the frequency and inten-
sity of symptoms in hospitalised older patients without
cancer in need of palliative care [9].
Setting and participants
The patients were recruited from geriatric and internal
medicine wards of nine acute care hospitals (one teach-
ing hospital and eight general hospitals) in Belgium. Pa-
tients were not recruited from the palliative care wards
because in the Belgian healthcare system these specific
patients need to have limited life expectancy of a few
weeks to 3 months.
A convenience sample of older palliative cancer and
non-cancer patients was invited to participate. Participants
were eligible if they (i) were ≥65 years, (ii) were diagnosed
with cancer, heart failure, obstructive lung disease, renal
failure, or liver failure, (iii) were in the palliative phase of
their disease, (iv) were able to communicate with the re-
searcher, and (v) were able to provide written informed
consent. Patients in the terminal phase of their disease
were excluded. Patients in need of palliative care and pa-
tients in the terminal phase of their disease were defined
by a set of criteria developed by a panel of experts (n = 7)
with clinical expertise in oncology, palliative care and/or
geriatric care. The criteria were based on definitions re-
ported in the literature [1, 10–13]. This resulted in the fol-
lowing criteria for patients in need of palliative care:
“Patients suffering from an incurable disease based on
treatment options, general condition of the patient, multi-
pathology and patient preferences. In contrast to healing,
stabilisation of the disease is possible.” For patients in the
terminal phase, the following criteria were used: “The last
phase of life, as characterised by global organ failure that
is clinically apparent in physical (e.g., respiratory) and
mental (e.g., agitation) changes.”
Instruments
Symptoms in cancer patients
The frequency and intensity of symptoms were collected
using the Assessment Symptoms Palliative Elderly (ASPE)
[14]. This instrument was developed to assess the frequency
and intensity of symptoms in older palliative cancer pa-
tients. The instrument has shown good validity and reliabil-
ity. In total, 40 symptoms (Fig. 1), including 24 physical, 10
psychological, and 3 functional symptoms and 2 items in
the social and 1 item in the spiritual domain, were mea-
sured on (i) a 5-point Likert scale to assess frequency (0 =
never; 1 = rarely; 2 = sometimes; 3 = often; 4 = always) and
(ii) a 4-point Likert scale to assess intensity (0 = not; 1 =
somewhat; 2 =moderate; 3 = very serious). The intensity of
symptoms was assessed if the patient scored the frequency
of the symptom as a 1 to 4. The ‘weight loss’ item had a
dichotomised answer category (‘yes’ or ‘no’).
Symptoms in non-cancer patients
An adapted version of the ASPE was used. Based on a lit-
erature review of instruments developed to assess the
symptoms of adults with heart failure, obstructive lung
disease, renal failure and liver failure, eight items were
added to the ASPE to increase the content validity of the
instrument for non-cancer patients. These eight additional
items were not included in the comparison analysis, be-
cause these items were not collected in the cancer group.
Demographic and clinical variables
Demographic and clinical variables were collected using
a standardised form. The demographic variables were as
follows: age, gender, living status, and living arrange-
ments. The clinical variables included the following: type
of illness for which the patient was considered in need
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of palliative care and the Flemish Triage Risk Screening
Tool (fTRST) [15]. The fTRST is a screening tool which
includes five items scored as present or absent [15]. The
total score ranges between 0 and 5, in which a score ≥ 2
indicates having a geriatric risk profile [15].
Data collection
In the period between March 2013 and June 2015, the re-
searchers contacted the participating wards weekly to
identify eligible patients. The responsible physician of the
participating wards classified the patients as being in need
of palliative care, in a terminal phase, or none of the previ-
ous two. After that a researcher approached the patients
who met the inclusion criteria. Two researchers collected
data on the frequency and intensity of symptoms. One re-
searcher (AVL) collected data from the cancer patients,
whereas the other researcher (MM) collected data from
the non-cancer patients. The researchers completed the
ASPE, the demographic variables and the fTRST based on
a structured interview with the patient. The instructions
and guidance provided by the researchers were reduced to
a minimum and were standardised to improve the validity
of the results. The first author (AVL), who developed the
instrument and was therefore familiar with its use, ex-
plained the application of the instrument to the second re-
searcher (MM) to optimise consistency in data collection.
Information on the type of illness was collected through
the electronic medical and paramedical records of the pa-
tients or was obtained from the responsible medical doc-
tor or nurse.
Ethical approval
Ethical approval was obtained from the ethics review
committee of the teaching hospital (University Hospital
Ghent) and general hospitals (Maria Middelares Hospital
Ghent, General Hospital Sint-Lucas Ghent, Onze-Lieve-
Vrouw van Lourdes Hospital Waregem, General Hos-
pital Sint-Lucas Bruges, General Hospital Alma Eeklo,
Onze Lieve Vrouw Hospital Alost, General Hospital
Nikolaas, Sint-Andries Hospital Tielt) (B670201317036
and B670201523233). The participants received oral in-
formation about the aim of the study from a healthcare
professional within the hospital. After preliminary con-
sent, the researcher approached the participant to pro-
vide more detailed information about both the aim of
the study and the participant’s anonymity. Written in-
formed consent was obtained from all participants.
Data analysis
Descriptive data were reported as the mean values with a
standard deviation for normally distributed continuous var-
iables, median values with 25th – 75th interquartile ranges
Fig. 1 Frequency and Intensity of Symptoms in Older Cancer and Non-Cancer Patients. Mean values are presented. For frequency values ranged
from 0 to 4, with 4 indicating always present. For intensity, values ranged from 0 to 3, with 3 indicating high intensity
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for ordinal variables, and percentages for nominal variables.
To improve the interpretation of the results, mean values
with a standard deviation were also provided for the com-
parison of the frequency and intensity of symptoms be-
tween groups (cancer and non-cancer patients).
In the study in older palliative cancer patients, 400 pa-
tients participated. In the second study, 100 older pallia-
tive non-cancer patients participated. Cancer patients
were significantly younger than non-cancer patients
(75.68 years versus 81.02 years, t (498) = 6.17, p < 0.001)
and significantly fewer cancer patients (72.5%) had a
geriatric risk profile compared to the non-cancer pa-
tients (90.0%) (χ2 (1) = 13.43; p < 0.001). To control for
age and geriatric risk profile, 100 cancer patients were
matched to the 100 non-cancer patients on these two
variables. The matching variables had to be identical to
allow two patients to be matched. If more than one pa-
tient could be matched with another patient, an ad
random match was drawn using a random number list
in SPSS. A match was found for all cases. Only those
200 patients were included in the analysis. No missing
data were present.
The difference in symptoms between both groups was
measured using an independent sample t-test for continu-
ous variables, Wilcoxon Mann-Whitney U-test for ordinal
variables and Chi-square test for nominal variables.
A p-value < 0.05 was considered statistically signifi-
cant. Data were analysed using SPSS, version 22
(Chicago, IL, USA).
Results
Demographics
A total of 200 patients were included in the analysis
(Table 1). Of these, 100 patients had a primary diagnosis of
cancer, and the remaining patients had a primary diagnosis
of heart failure (22.5%), obstructive lung disease (13.5%),
Table 1 Demographic and Clinical Characteristics of Patients (N = 200)
Total sample (N = 200) Cancer patients (N = 100) Non-cancer patients (N = 100)
Mean (SD) N (%) Mean (SD) N (%) Mean (SD) N (%)
Age (years) 81.1 (7.8) 81.12 (7.5) 81.02 (8.0)
Gender
Male 99 (49.5) 49 (49.0) 50 (50.0)
Female 101 (50.5) 51 (51.0) 50 (50.0)
Living status
Married 92 (46.0) 53 (53.0) 39 (39.0)
Widow/widower 81 (40.5) 35 (35.0) 46 (46.0)
Unmarried 27 (13.5) 12 (12.0) 15 (15.0)
Living arrangements
Living alone 76 (38.0) 35 (35.0) 41 (41.0)
Living with partner 94 (47.0) 53 (53.0) 41 (41.0)
Living with others 30 (15.0) 12 (12.0) 18 (18.0)
Pathology
Cancer 100 (50.0) 100 (100.0)
Heart failure 45 (22.5) 45 (45.0)
Obstructive lung disease 27 (13.5) 27 (27.0)
Renal failure 25 (12.5) 25 (25.0)
Liver failure 3 (1.5) 3 (3.0)
Type of admitted ward
Internal ward 154 (77.0) 82 (82.0) 72 (72.0)
Geriatric ward 46 (23.0) 18 (18.0) 28 (28.0)
Number of comorbidities 2.1 (1.6) 2.2 (1.6) 2.1 (1.6)
fTRSTa
No risk profile 25 (12.4) 15 (15.0) 10 (10.0)
Geriatric risk profile 175 (87.5) 85 (85.0) 90 (90.0)
No statistical differences between the groups were observed using the independent sample t-test for continuous variables and the Chi-square test for nominal
variables. SD: Standard Deviation; N: number of patients. afTRST: Flemish Triage Risk Screening Tool. A score of ≥ 2 represents a geriatric risk profile, while a score
of 0 and 1 is considered to be normal
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renal failure (12.5%), or liver failure (1.5%). Approximately
49.5% were men, and 50.5% were women. The mean age of
the patients was 81.1 years (SD 7.8). Most patients had a
geriatric risk profile (87.5%). More cancer patients (53.0%)
were married and still lived with their partner as opposed
to the non-cancer patients (39.0%). There were no signifi-
cant differences between the cancer and non-cancer pa-
tients in demographic or clinical characteristics.
Difference in number of symptoms
On average, patients reported 17.28 symptoms (SD 5.05;
range 6–31) (Table 2). Cancer patients reported signifi-
cantly fewer symptoms than non-cancer patients (t (198)
= 2.72; p = 0.007). Cancer patients reported significantly
fewer physical symptoms (Fig. 1) than non-cancer patients
(t (198) = 2.49; p = 0.013). Significantly fewer cancer pa-
tients (79.0%) experienced functional dependence com-
pared to non-cancer patients (90.0%) (χ2 (1) = 4.62; p =
0.032). There was no significant difference between the
two groups for the number of psychological symptoms.
Difference in frequency of symptoms
The frequency of symptoms in both patient groups is dis-
played in Figure 1. The five symptoms with the highest fre-
quency in cancer patients were dry mouth, physical fatigue,
difficulties moving outside, difficulties with self-care, and
lack of energy. The five symptoms with the highest fre-
quency in non-cancer patients were difficulties moving out-
side, difficulties with self-care, lack of energy, difficulties
moving inside, and shortness of breath. The differences in
the symptom frequency between cancer and non-cancer
patients are presented in Table 3. Cancer patients reported
significantly higher frequencies compared to non-cancer
patients for physical fatigue (Z = − 2.78; p = 0.005), psycho-
logical pain (Z = − 2.16; p = 0.031), and not being satisfied
with social life (Z =− 3.46; p = 0.001). Non-cancer patients
reported significantly higher frequencies of the following
symptoms compared to cancer patients: shortness of breath
(Z = − 2.16; p = 0.031), itching (Z = − 2.07; p = 0.038), airway
mucus (Z = − 2.01; p = 0.045), confusion (Z = − 2.46; p =
0.014), lack of willpower (Z =− 5.01; p < 0.001), difficulties
with self-care (Z = − 2.00; p = 0.045), difficulties moving
inside (Z = − 4.64; p < 0.001), and difficulties moving out-
side (Z = − 2.71; p = 0.007).
Differences in intensity of symptoms
The intensity of symptoms in both patient groups is dis-
played in Figure 1. The following five symptoms reported
by at least 50% of the cancer patients received the highest
intensity: psychological fatigue, brooding, physical fatigue,
lack of energy, and psychical pain. The following five symp-
toms were reported by at least 50% of the non-cancer pa-
tients as being the highest intensity: lack of energy, physical
pain, lack of willpower, airway mucus, and physical fatigue.
The differences in intensity of symptom between cancer
and non-cancer patients are presented in Table 3. Cancer
patients reported significantly higher intensity levels than
non-cancer patients for psychological fatigue (Z = − 3.10; p
= 0.002), brooding (Z = − 3.83; p < 0.001), tension (Z = −
2.22; p = 0.026), and anger (Z = − 2.29; p = 0.022). Non-
cancer patients reported significantly higher intensity levels
compared to cancer patients for physical pain (Z = − 2.30;
p = 0.021), shortness of breath (Z = − 4.15; p < 0.001), lack
of willpower (Z = − 3.39; p = 0.001), difficulties with self-
care (Z = − 2.34; p = 0.019), and perceiving life as not mean-
ingful (Z = − 3.75; p < 0.001).
Discussion
This study is the first to evaluate the differences in symp-
tom patterns between older hospitalised palliative cancer
and non-cancer patients. Overall, similarities in symptom
patterns could be observed between cancer and non-cancer
patients. Patients in both groups experienced problems
with functionality, physical fatigue, lack of energy, shortness
of breath and physical pain with a high frequency and phys-
ical fatigue, lack of energy, and physical pain with a high in-
tensity. Similar symptom patterns were also observed in the
systematic reviews of Solano et al. (2006) and Moens et al.
(2014) concerning the prevalence of symptoms in palliative
patients with different diseases [4, 5]. Although the ranking
in frequency and intensity of symptoms was similar in both
groups, some minor differences could be observed in the
frequency and intensity of symptoms. Non-cancer patients
experienced significantly more physical symptoms and
functional dependence compared to cancer patients. In
Table 2 Number of Symptoms per Patient (N = 200)
Total sample (N = 200) Cancer patients (N = 100) Non-cancer patients (N = 100) t df p-value
Mean (SD) Mean (SD) Mean (SD)
All symptomsa 17.28 (5.05) 16.32 (4.80) 18.23 (5.13) 2.72 198 0.007
Physical symptomsa 9.14 (3.22) 8.58 (3.05) 9.70 (3.30) 2.49 198 0.013
Psychological symptomsa 3.70 (2.48) 3.73 (2.47) 3.66 (2.44) −0.20 198 0.840
Functional dependenceb 169 (84.5) 79 (79.0) 90 (90.0) 4.62 1 0.032
aThe maximal number of symptoms was 40. The maximal number of physical symptoms was 24. The maximal number of psychological symptoms was 10.
bFunctional dependence defined as experiencing difficulties on at least one functional item (self-care, moving inside, and moving outside) was a dichotomous
variable. Therefore numbers with percentages instead of means with SD are reported. The difference between groups was assessed using the Chi-square test
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addition, the frequency and intensity of functional depend-
ence were significantly higher for non-cancer patients com-
pared to the cancer group. A possible explanation of this
finding could be that interventions to decrease symptoms
focus more on palliative cancer patients than on non-
cancer patients. Only in recent years has research empha-
sised that more attention should be paid to palliative non-
cancer patients [3, 4]. A few physical symptoms occurred
more often in cancer patients such as physical fatigue and
dry mouth. These symptoms are common side effects of
chemotherapy.
Regarding psychological symptoms, no differences were
observed between the groups in terms of the number of
psychological symptoms per patient. However, when
examining the individual symptoms, cancer patients ap-
peared to experience a higher frequency and intensity of
psychological symptoms, with the exception of lack of
willpower. The high frequency and intensity of psycho-
logical symptoms might be related to patients’ illness per-
ceptions, which help them make sense of their
experienced symptoms and subsequently guide their cop-
ing strategies [16]. For patients without cancer, the long-
lasting and fluctuating nature of chronic illness presents a
challenge for identifying ways to cope with their illness
[17]. In contrast, a cancer diagnosis is marked by an im-
mediate change from well-being to feelings of uncertainty
and the threat of death [18].
Implications for clinical practice and research
The occurrence and intensity of symptoms were high in
both older palliative cancer and non-cancer patients. It
is worth noting that patients in the present study were
not patients in a terminal phase, indicating that multiple
symptoms with a high frequency and intensity are
already experienced before the end-of-life stage. Accord-
ingly, attention should be devoted to older patients’ ex-
perience of symptoms in the palliative phase to decrease
the frequency and intensity of their symptoms. Health-
care professionals should be sensitised to this high
symptom occurrence in both cancer and non-cancer pa-
tients. In addition, they should be educated on system-
atic symptom assessment in multiple domains.
Additionally, the commonalities in symptom patterns
indicate that both cancer and non-cancer patients may
need support in reducing symptom burden. A referral to
palliative care should therefore be based on the needs of
the individual patient, rather than diagnosis-based. This
was also emphasised by Moens et al. [4] and Solano et al.
[5] in their review. Both patient groups might benefit from
a referral to palliative support teams. These teams are spe-
cialised in managing symptoms to improve quality of life,
and the literature indicates that an early referral to pallia-
tive care increases patients’ quality of life [19]. For clini-
cians, it is difficult to identify when patients should be
referred to palliative care [3]. This is especially true for
non-cancer patients because of the unpredictable course
of their illness [3]. Despite this challenge, healthcare pro-
fessions should be educated about referring patients to
palliative care early on in their care which should be based
on the patient’s needs. Moreover, to improve this referral,
attention should be paid to patient, and professional-
related barriers to referring patients to palliative care, such
as a lack of knowledge and an inadequate perception of
palliative care [3]. Also, a referral to a specialised geriatric
care team might be beneficial for patients who are con-
fronted with age-related disability, chronic conditions, de-
creased functionality and psychosocial problems and the
care goal is to increase the patient’s independence, phys-
ical and mental health and functionally [20, 21]. Health-
care professionals could use a screening tool in older
patients to identify those patients in need of a further geri-
atric evaluation [22]. Nevertheless, the benefits of referral
should be weighed against the risk of fragmentation of
care when involving different healthcare professionals.
The observed differences between cancer and non-
cancer patients indicate that there are some disease-
specific differences that should be addressed in clinical
practice. Healthcare professionals should devote atten-
tion to both generic symptoms and disease-specific
symptoms. Education on these aspects is advised.
In the present study, cancer and non-cancer patients
were compared. Further research could evaluate the dif-
ferences in symptoms between different non-cancer pa-
tient groups. This was not possible in the present study
due to small number of patients in the subgroups of
non-cancer patients (range 3–45).
Strengths and limitations
This study has some strengths and limitations. To our
knowledge, this study is the first to evaluate the differ-
ences in symptoms between older hospitalised palliative
cancer and non-cancer patients using the same instru-
ment and time point to evaluate symptoms. This
consistency enhanced the validity of the results. A limita-
tion of the present study is the possible difference between
groups in terms of additional, non-collected demographic
and clinical variables. Nevertheless, both groups were
matched for age and geriatric risk profile to decrease a
possible influence of these factors on the outcomes. The
matched cancer patients were older and had a higher geri-
atric risk profile compared to the original sample. Conse-
quently, the cancer group might be less representative for
the larger population. Also, the difference in the provision
of palliative care between the two groups was not evalu-
ated. Nevertheless, patients were recruited from the same
hospitals and the difference in symptoms was minimal
which might imply that the palliative care provision was
rather similar between the two patient groups. Another
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limitation was the possible risk of systematic and re-
searcher bias in the data-collection because the data was
collected by two researchers. To overcome this, the sec-
ond researcher was instructed by the primary researcher.
Conclusion
Similarities in symptom patterns could be observed between
cancer and non-cancer patients. In both groups, a high fre-
quency was observed for functionality, physical fatigue, lack
of energy, shortness of breath, and physical pain, and a high
intensity was observed for physical fatigue, lack of energy,
and physical pain. Despite these similarities, non-cancer pa-
tients experienced significantly more physical symptoms
and functional dependence compared to cancer patients,
and cancer patients experienced a higher frequency and in-
tensity of psychological symptoms. Nevertheless, the similar-
ities were larger than the differences which indicates that a
need-based referral to palliative care would be more benefi-
cial than a diagnoses-based referral. Healthcare professionals
should be sensitised to the high symptom occurrence in
both cancer and non-cancer patients. Additionally, they
should be educated about systematic symptom assessment
in multiple domains by accounting for the occurrence of
generic symptoms and disease-specific symptoms.
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